Wire · opportunities
Finding drug targets in the tissue context with spatial biology
◆ Sectors
◆ Source
◆ Verified
Fusion42 · 17 August 2026 · Fusion42 review
Spatial biology enhances drug target discovery by preserving tissue context, enabling identification of both cell-type-specific and location-dependent targets that bulk and single-cell sequencing alone cannot reveal.
This Wire brief sits within Fusion42's coverage of Biotech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.
◆ ◆ The Wire takeaway
Biotech founders using drug discovery need to integrate spatial data to refine and validate targets beyond single-cell approaches. Your next screening pipeline should layer spatial biology onto genetics to avoid missing location-specific therapeutic targets.
◆ Related on Wire
◆ Topics